AbCellera Biologics Inc
ABCL
Market Cap$718.15M
Close$
$-1.58
178.6% downside
Current Fair Value
178.6% downsideOvervalued by 178.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $718.15 Million |
|---|---|
| Enterprise Value | $636.09 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.55 |
| Beta | 0.49 |
| Outstanding Shares | 295,757,002 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.38 |
|---|---|
| PEG | -5.57 |
| Price to Sales | - |
| Price to Book Ratio | 2.01 |
| Enterprise Value to Revenue | 19.3 |
| Enterprise Value to EBIT | -2.32 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data